ST葫芦娃：预计2025年度净利润为-2.1亿元到-3.1亿元

Group 1 - The company ST HuLuWa expects a net loss attributable to shareholders of the parent company between -210 million to -310 million yuan for the year 2025, indicating a decline compared to the same period last year [1] - The primary reasons for the performance change include adjustments in industry policies and market environment, leading the company to proactively modify the sales model for certain clients and optimize marketing channel layouts, resulting in decreased product sales and gross margin levels [1] - The completion and capitalization of the Haikou Meian Children's Medicine Intelligent Manufacturing Base and the second phase of the Guangxi Weiwei production base have led to increased fixed asset depreciation expenses, alongside rising bank loan interest expenses and ongoing R&D investments, which have negatively impacted the company's operating performance for the reporting period [1] Group 2 - Despite facing challenges from industry fluctuations, the company has implemented relevant countermeasures, including optimizing customer management, promoting customer tiered management, and enhancing cooperation depth with high-quality clients [1] - The company is also focusing on deepening cost control and improving operational efficiency through refined management practices, strictly controlling expenditure, and striving to enhance operating performance by reducing costs and increasing efficiency [1]